134 related articles for article (PubMed ID: 24870773)
1. Schedule-dependent effects of kappa-selenocarrageenan in combination with epirubicin on hepatocellular carcinoma.
Ji YB; Ling N; Zhou XJ; Mao YX; Li WL; Chen N
Asian Pac J Cancer Prev; 2014; 15(8):3651-7. PubMed ID: 24870773
[TBL] [Abstract][Full Text] [Related]
2. Immuno-modulatory and cellular antioxidant activities of κ-selenocarrageenan in combination with Epirubicin in H22 hepatoma-bearing mice.
Ling N; Zhou X; Ji Y; Li W; Ji C; Qi Z
Biomed Pharmacother; 2017 Jul; 91():132-137. PubMed ID: 28448867
[TBL] [Abstract][Full Text] [Related]
3. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway.
Wu F; Chen WJ; Yan L; Tan GQ; Li WT; Zhu XJ; Ge XC; Liu JW; Wang BL
Cancer Med; 2016 Feb; 5(2):370-85. PubMed ID: 26714930
[TBL] [Abstract][Full Text] [Related]
4. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
[TBL] [Abstract][Full Text] [Related]
5. HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells.
Zhang N; Wu Y; Lyu X; Li B; Yan X; Xiong H; Li X; Huang G; Zeng Y; Zhang Y; Lian J; Ni Z; He F
Cancer Lett; 2017 Nov; 409():81-90. PubMed ID: 28889000
[TBL] [Abstract][Full Text] [Related]
6. Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.
Song B; Bian Q; Shao CH; Li G; Liu AA; Jing W; Liu R; Zhang YJ; Zhou YQ; Hu XG; Jin G
PLoS One; 2015; 10(3):e0120694. PubMed ID: 25815885
[TBL] [Abstract][Full Text] [Related]
7. Improved antitumor activity and reduced cardiotoxicity of epirubicin using hepatocyte-targeted nanoparticles combined with tocotrienols against hepatocellular carcinoma in mice.
Nasr M; Nafee N; Saad H; Kazem A
Eur J Pharm Biopharm; 2014 Sep; 88(1):216-25. PubMed ID: 24813390
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib enhances the therapeutic efficacy of epirubicin for Novikoff hepatoma in rats.
Chu TH; Chan HH; Hu TH; Wang EM; Ma YL; Huang SC; Wu JC; Chang YC; Weng WT; Wen ZH; Wu DC; Chen YA; Tai MH
Cancer Med; 2018 Jun; 7(6):2567-2580. PubMed ID: 29683262
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase receptor inhibitor-targeted combined chemotherapy for metastatic bladder cancer.
Wu CL; Ping SY; Yu CP; Yu DS
Kaohsiung J Med Sci; 2012 Apr; 28(4):194-203. PubMed ID: 22453067
[TBL] [Abstract][Full Text] [Related]
10. Progesterone increases epirubicin's apoptotic effects in HepG2 cells by S phase cell cycle arrest.
Chang WT; Lin HL; Chang KL; Ker CG; Huang MC; Chen JS; Kuo KK; Chen YL; Lee KT
Hepatogastroenterology; 2010; 57(97):107-13. PubMed ID: 20422883
[TBL] [Abstract][Full Text] [Related]
11. Involvement of Chk1-Cdc25A-cyclin A/CDK2 pathway in simvastatin induced S-phase cell cycle arrest and apoptosis in multiple myeloma cells.
Tu YS; Kang XL; Zhou JG; Lv XF; Tang YB; Guan YY
Eur J Pharmacol; 2011 Nov; 670(2-3):356-64. PubMed ID: 21958871
[TBL] [Abstract][Full Text] [Related]
12. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
[TBL] [Abstract][Full Text] [Related]
13. Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.
Zoli W; Ricotti L; Tesei A; Ulivi P; Gasperi Campani A; Fabbri F; Gunelli R; Frassineti GL; Amadori D
Clin Cancer Res; 2004 Feb; 10(4):1500-7. PubMed ID: 14977854
[TBL] [Abstract][Full Text] [Related]
14. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
15. In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug.
Shi XN; Li H; Yao H; Liu X; Li L; Leung KS; Kung HF; Lu D; Wong MH; Lin MC
PLoS One; 2015; 10(7):e0132072. PubMed ID: 26147897
[TBL] [Abstract][Full Text] [Related]
16. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
[TBL] [Abstract][Full Text] [Related]
17. Differences in Transport Characteristics and Cytotoxicity of Epirubicin and Doxorubicin in HepG2 and A549 Cells.
Nagai K; Fukuno S; Shiota M; Tamura M; Yabumoto S; Konishi H
Anticancer Res; 2021 Dec; 41(12):6105-6112. PubMed ID: 34848465
[TBL] [Abstract][Full Text] [Related]
18. Epirubicin may enhance the inhibition of hepatocellular carcinoma induced by iodine-125 seeds through downregulating WNT pathway.
Tian S; Lu Y; Gao H; Chen Z; Niu M; Wang C; Liu B
Asia Pac J Clin Oncol; 2023 Jun; 19(3):355-364. PubMed ID: 36464954
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
20. Berberine promotes antiproliferative effects of epirubicin in T24 bladder cancer cells by enhancing apoptosis and cell cycle arrest
.
Zhuo Y; Chen Q; Chen B; Zhan X; Qin X; Huang J; Lv X
Int J Clin Pharmacol Ther; 2017 Jan; 55(1):32-40. PubMed ID: 27719740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
